News for Vor Biopharma Inc. (VOR)

Vor Biopharma's trem-cel offers hope for AML treatment, but financial risks and early-stage progress suggest caution. Learn more about VOR stock here.

Transaction Overview On December 31, 2024, FMR LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in Vor Biopharma Inc (VOR) by 651,477 sh

Is it a good or bad thing when a stock experiences a golden cross technical event?

Vor biopharma sees significant stock acquisition by Reid Hoffman

RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio), a prominent investment firm, has recently increased its stake in Vor Biopharma Inc by acquiring an additional 1

Friday's private investment in public equity transaction valued at $55.6 million by Vor Biopharma Inc. (VOR, Financials) sent its stock price skyrocketing 46.78

Vor Biopharma Inc. (VOR), Friday announced a securities purchase agreement for a private investment in public equity financing for approximately $55.6 million. Currently, shares are at $0.

OpenAI and Nvidia are at the forefront of the AI revolution, according to Dan Ives.

Vor Biopharma stock plunges to 52-week low of $0.69

Shares of Oracle Corporation ORCL rose sharply in today's pre-market trading after the company reported better-than-expected earnings and sales results for its ...

Shares of Argan, Inc. AGX rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results. Argan re...

Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Read Equities Research Analysts’ Downgrades for May 18th (APO, APPF, AZN, BYCBF, CARR, CCBG, CENX, CF, CLH, CRH) at ETF Daily News

Three clinical-stage, wholly-owned candidates being advanced across range of indications, including two Phase 2 trials of LYT-100 , a Phase 1/2 trial of LYT-200 and a Phase 1 study of LYT-300 Key... | December 16, 2021

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors CAMBRIDGE, Mass., / PRNewswire/ -- Blueprint Medicines Corporation today announced the appointment of... | December 10, 2021

GuruFocus Article or News written by insider and the topic is about:

During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the ...

Before 10 a.m. ET Friday, 117 stocks made new 52-week lows. Interesting Points: China Life Insurance Co (NYSE:LFC) was the biggest company in ...